Trial
NCT02020616
A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Type 2 Diabetes Mellitus
Intervention
LY3053102
Why stopped
Lack of Efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-10-08